Tuvalu Business Day: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tuvalu Business Day.

Press releases published on May 12, 2026

2 hours ago

Skyward Specialty Appoints Melissa Goto to Lead E&S Brokerage and Inland Marine Businesses

Indeterminate GlobeNewswire

2 hours ago

Aquestive Therapeutics Completes $150 Million Debt Refinancing with Oaktree

Indeterminate GlobeNewswire

2 hours ago

First Real-World Evidence Study of RYTELO® (imetelstat) in Lower-risk Myelodysplastic Syndromes (LR-MDS) to be Presented at EHA 2026 

Indeterminate GlobeNewswire

2 hours ago

[Latest] Industrial Lubricant Market Size Will Attain USD 102.90 Billion by 2034 Growing at 5.80% CAGR - Exclusive Report by Zion Market Research

Indeterminate GlobeNewswire

2 hours ago

21shares Launches THYP and TXXH, the First U.S. ETFs Tracking Hyperliquid

Indeterminate GlobeNewswire

2 hours ago

Evaxion to present new data for EVX-04, an off-the-shelf therapeutic vaccine for acute myeloid leukemia, at the EHA 2026 Congress

Indeterminate GlobeNewswire

2 hours ago

Ammonia Market worth $102.74 billion by 2031, at 3.71%, says MarketsandMarkets™

Indeterminate GlobeNewswire

2 hours ago

Beam Therapeutics to Present Updated Biomarker Data from Phase 1/2 BEACON Trial Further Underscoring Risto-cel’s Ability to Restore Red Blood Cell Health and Function in Sickle Cell Disease at EHA2026

Indeterminate GlobeNewswire

2 hours ago

Cogent Biosciences Announces Multiple Presentations at the European Hematology Association (EHA) 2026 Congress

Indeterminate GlobeNewswire

2 hours ago

Picogrid Joins U.S. Army’s “Right to Integrate” Sprint at Fort Carson to Accelerate Vendor-Neutral Interoperability

Indeterminate GlobeNewswire

2 hours ago

Disc Medicine Announces Multiple Presentations Across Portfolio at the European Hematology Association (EHA) 2026 Congress

Indeterminate GlobeNewswire

2 hours ago

Caribou Biosciences to Highlight Vispa-cel and CB-011 Programs During Oral Presentations at the 2026 European Hematology Association (EHA) Annual Meeting

Indeterminate GlobeNewswire

2 hours ago

BlossomHill Therapeutics to Present Initial Clinical Dose Escalation Data from the Phase 1/1b Trial of BH-30236 in Patients with R/R AML or HR-MDS at EHA2026

Indeterminate GlobeNewswire

2 hours ago

Agios to Present New Data at EHA 2026 Reinforcing the Significant Therapeutic Impact of Mitapivat Across Multiple Rare Hemolytic Anemias

Indeterminate GlobeNewswire

2 hours ago

Ajax Therapeutics Announces Oral Presentation of Clinical Results from AJX-101, a Phase I study of AJ1-11095, a First-in-Class Type II JAK2 Inhibitor, at the European Hematology Society (EHA) 2026 Congress

Indeterminate GlobeNewswire

2 hours ago

Alpha Compute Closes $32.2 Million Revenue Contract with AI Lab Customer

Indeterminate GlobeNewswire

2 hours ago

Cellectis to Present Clinical Data on Lasme-cel and Eti-cel at EHA 2026 Annual Congress

Indeterminate GlobeNewswire

2 hours ago

Cellectis présentera des données cliniques sur lasmé-cel et éti-cel au congrès annuel de l’EHA 2026

Indeterminate GlobeNewswire

2 hours ago

Independent Cleveland Clinic Review Finds No Clinically Significant Cardiotoxicity with Moleculin's Annamycin in R/R AML Patients Dosed Beyond Conventional Anthracycline Limits

Indeterminate GlobeNewswire

2 hours ago

South Street Securities Holdings Inc. Acquires 100% Equity Interest in Lime Funding LLC, an Asset-Backed Commercial Paper Conduit

Indeterminate GlobeNewswire